Stay updated on Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Sign up to get notified when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.

Latest updates to the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA sitewide NIH announcement about terminology during a website transition appears above the unchanged 403 error page. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content and indicating an access restriction to the page. This means the study details are not currently accessible through the page.SummaryDifference18%

- Check43 days agoChange DetectedA new Revision: v3.7.0 is shown, replacing the previous v3.6.6. This update reflects a metadata version change to the study record and does not alter substantive study information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a new revision of the study record rather than substantive content changes.SummaryDifference0.1%

- Check71 days agoChange DetectedA new publication citation has been added under Publications, listing a 2026 Adv Ther article on cenobamate in Chinese participants with focal seizures.SummaryDifference0.1%

Stay in the know with updates to Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.